Tradestie Institutional Equity Comparison Engine

MTNB vs OGEN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MTNB Overall Edge

MTNB Captures Institutional Edge (1โ€“0 Pillars ยท 4โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Matinas BioPharma Holdings, Inc. (MTNB) driven by superior Momentum & Technical. Fundamentally, MTNB trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus OGEN at N/M Forward P/E and 0.0% operating margin (-91.3% YoY). In options structure, MTNB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OGEN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MTNB N/M vs OGEN N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin 0.0% vs 0.0% ยท YoY -100.0% vs -91.3%
Momentum & Technical Winner MTNB
1Y -31.4% vs -84.1% ยท 52W Pos 22% vs 4%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
MTNB NYSE American
Matinas BioPharma Holdings, Inc.
Pharmaceutical Preparations
$0.81
-10.98% 1D
Market Cap $979,904
1M Return -46.7%
1Y Return -31.35%
Forward P/E N/M
Unified AI Score
54.6 / 100 HOLD
Tech 53.0 Fund 58.0 Flow 50.0 Mom 60.0
OGEN NYSE American
Oragenics Inc.
Pharmaceutical Preparations
$0.17
-8.99% 1D
Market Cap $852,759
1M Return -58.33%
1Y Return -84.11%
Forward P/E N/M
Unified AI Score
40.8 / 100 SELL
Tech 30.0 Fund 50.0 Flow 50.0 Mom 75.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MTNB -31.35% OGEN -84.11% Spread: +52.76 pp (MTNB Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period MTNB Revenue OGEN Revenue MTNB Op. Margin OGEN Op. Margin Margin Edge
FY2015 $0M N/A -5096.0% N/A MTNB
FY2017 $0M N/A -11024.6% N/A MTNB
FY2018 $0M N/A -12230.9% N/A MTNB
FY2019 $0M N/A -21067.4% N/A MTNB
FY2020 $0M N/A -15288.4% N/A MTNB
FY2021 $0M $0M -74954.5% -18130.3% OGEN
FY2022 $0M $0M -771.3% -10964.6% MTNB
FY2023 $0M $0M -2168.4% -55519.9% MTNB

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MTNB (4) vs OGEN (1)
Institutional Metric MTNB OGEN Criterion Row Winner
Market Capitalization Scale $979,904 $852,759 Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -100.0% -91.3% Higher Growth OGEN
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -147.5% -1307.1% Higher ROE MTNB
52-Week Range Position Momentum 22% ($0โ€“$3) 4% ($0โ€“$1) Stronger Trend MTNB
Beta / 30D Volatility Risk Regime -7.20ฮฒ ยท 147% Vol 1.23ฮฒ ยท 154% Vol Lower Realized Risk MTNB
Unified Institutional Score Composite Signal 54.6 / 100 (HOLD) 40.8 / 100 (SELL) Higher Composite MTNB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MTNB vs OGEN Buy Guide
MTNB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MTNB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OGEN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OGEN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MTNB nor OGEN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.